In Vitro and in Vivo Development of a Topical Drug for the Treatment of Equine Skin Cancer - Based on Naturally Occurring and Synthetically Modified Substances in Plane Bark
In Vitro and in Vivo Development of a Topical Drug for the Treatment of Equine Skin Cancer - Based on Naturally Occurring and Synthetically Modified Substances in Plane Bark
In Vitro and in Vivo Development of a Topical Drug for the Treatment of Equine Skin Cancer - Based on Naturally Occurring and Synthetically Modified Substances in Plane Bark - Lisa Annabel Weber
Cheaper New Book
Imported
to France
*
Delivery: 10 Dec - 17 Dec
Shipping: 7 to 11 business days.
17,68 €
Faster New Book
Imported
to France
*
Delivery: 03 Dec - 05 Dec
Shipping: 3 to 4 business days.
17,85 €
* Import costs and 5.5% VAT included in the price ✅
17,68 €
Delivery to any France address between Wednesday, December 10 and Wednesday, December 17
Shipping
Origin: United Kingdom
Import costs included in the price ✅
Delivery to any France address between Wednesday, December 10 and Wednesday, December 17.
17,85 €
Delivery to any France address between Wednesday, December 03 and Friday, December 05
Shipping
Origin: United Kingdom
Import costs included in the price ✅
Delivery to any France address between Wednesday, December 03 and Friday, December 05.
Choose the list to add your product or create one New List
In Vitro and in Vivo Development of a Topical Drug for the Treatment of Equine Skin Cancer - Based on Naturally Occurring and Synthetically Modified Substances in Plane Bark
Lisa Annabel Weber
Synopsis "In Vitro and in Vivo Development of a Topical Drug for the Treatment of Equine Skin Cancer - Based on Naturally Occurring and Synthetically Modified Substances in Plane Bark"
Equine sarcoids (ES) and equine malignant melanoma (EMM) are among the tumors affecting horses diagnosed most frequently. Both cutaneous neoplasms can be a significant cause of economic losses, morbidity and mortality in the animals. The treatment of equine skin cancer can be challenging and established, evidence-based therapies resulting in sustained tumor regression are rare. The pentacyclic, lupane-type triterpenes betulinic acid (BA) and betulin can be isolated from many botanical sources, predominantly from the bark of white birch and plane trees. In addition to various biological properties, they have gained attention mainly due to their anticancer features. Within the framework of the current PhD project, the compounds BA, BA derivative NVX-207, and betulin derivative betulinyl-bis-sulfamate were assessed in various in vitro and in vivo studies for their potential as a topical therapy for ES and EMM. In conclusion, the results generated from cell culture experiments, skin permeation assays and studies in the target species are promising. Further advancement of the investigational medicinal products studied herein could lead to an effective topical and marketable, novel drug which helps to relieve suffering and, consequently, improve the welfare of equine skin cancer patients.